ITRM logoITRM
Iterum Therapeutics Plc

26,617
Loading...
Loading...
News
all
press releases
Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections Iterum Therapeutics to Host Morning...
PR Newswire·11mo ago
News Placeholder
More News
News Placeholder
Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC Research Report), Apollomics (AP...
TipRanks Financial Blog·1y ago
News Placeholder
Q4 2023 Iterum Therapeutics PLC Earnings Call Transcript
Related Stocks: NAS:ITRM...
GuruFocus·1y ago
News Placeholder
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. The post ITRM...
InvestorPlace·1y ago
News Placeholder
Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript
Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript...
SeekingAlpha·1y ago
News Placeholder
Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript
Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript...
Seeking Alpha: Transcripts·1y ago
News Placeholder
Iterum Therapeutics sees cash runway into 2025
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Iterum Therapeutics reports Q4 EPS (81c) vs. (52c) last year
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
--Resubmission of NDA On Track for Early Q2 24 --Cash Runway into 2025, including through Potential FDA Approval in Early Q4 24-- --Company to host conference call today at 8:30amET-- DUBLIN...
Globe Newswire·1y ago
News Placeholder
Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
DUBLIN, Ireland and CHICAGO, March 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation...
Globe Newswire·1y ago

Latest ITRM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.